Class II · Moderate risk Ongoing
Methohexital Sodium
Reason Failed Impurities/Degradation Specifications
Methohexital
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility
What was recalled
Methohexital (Brevital Sodium) 10 mg/mL,10 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0180-72
- Recalling firm
- Pharmakon Pharmaceuticals, Inc.
- NDC code
- 45183-0180-72
- Origin
- IN, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1274-2016
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Methohexital recalls
See all
Class II · Moderate risk Ongoing
Methohexital Sodium for Injection
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Terminated
Methohexital Sodium all strengths
Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.